These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7061105)

  • 1. Activation of platelets by modified C-reactive protein.
    Fiedel BA; Simpson RM; Gewurz H
    Immunology; 1982 Mar; 45(3):439-47. PubMed ID: 7061105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor.
    Fiedel BA; Siegel JN; Gewurz H; Simpson RM; Izzi JM
    Clin Exp Immunol; 1982 Oct; 50(1):215-22. PubMed ID: 7172507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of C-reactive protein on platelet function. I. Inhibition of platelet aggregation and release reactions.
    Fiedel BA; Gewurz H
    J Immunol; 1976 May; 116(5):1289-94. PubMed ID: 58027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of C-reactive protein on platelet function. III. The role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion.
    Fiedel BA; Simpson RM; Gewurz H
    J Immunol; 1977 Sep; 119(3):877-82. PubMed ID: 70475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.
    Potempa LA; Zeller JM; Fiedel BA; Kinoshita CM; Gewurz H
    Inflammation; 1988 Aug; 12(4):391-405. PubMed ID: 2459061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet inhibitory effects of CRP preparations are due to a co-isolating low molecular weight factor.
    Fiedel BA; Potempa LA; Frenzke ME; Simpson RM; Gewurz H
    Immunology; 1982 Jan; 45(1):15-22. PubMed ID: 7056562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of platelet activation by the amyloid P-component of serum.
    Fiedel BA; Ku CS; Izzi JM; Gewurz H
    J Immunol; 1983 Sep; 131(3):1416-9. PubMed ID: 6886420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species.
    Miyazawa K; Kiyono S; Inoue K
    J Immunol; 1988 Jul; 141(2):570-4. PubMed ID: 3385211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour.
    Fiedel BA
    Immunology; 1988 Jul; 64(3):487-93. PubMed ID: 3044982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions.
    Boncler M; Rywaniak J; Sicinska P; Watala C
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):301-9. PubMed ID: 21372690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and the acute phase response.
    Gewurz H; Mold C; Siegel J; Fiedel B
    Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of C-reactive protein on human lymphocyte responsiveness.
    Vetter ML; Gewurz H; Hansen B; James K; Baum LL
    J Immunol; 1983 May; 130(5):2121-6. PubMed ID: 6220082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity.
    James K; Hansen B; Gewurz H
    J Immunol; 1981 Dec; 127(6):2539-44. PubMed ID: 7028874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae.
    Mold C; Gewurz H
    J Immunol; 1981 Nov; 127(5):2089-92. PubMed ID: 6913608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM; Gewurz H; Lint TF; Mold C
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pravastatin and C reactive protein modulate protease- activated receptor-1 expression in vitro blood platelets.
    Chu LX; Zhou SX; Yang F; Qin YQ; Liang ZS; Mo CG; Wang XD; Xie J; He LP
    Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):75-80. PubMed ID: 26950455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy.
    Danenberg HD; Kantak N; Grad E; Swaminathan RV; Lotan C; Edelman ER
    Eur J Haematol; 2007 Mar; 78(3):246-52. PubMed ID: 17253971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of C-reactive protein (CRP) on platelet function.
    Fiedel BA; Simpson RM; Gewurz H
    Ann N Y Acad Sci; 1982; 389():263-73. PubMed ID: 7046580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.